[Cholinesterase inhibition in liver diseases by additional loading with BC 51 (ubretid)].
D001342:Autonomic Nervous System Diseases; D002802:Cholinesterases; D006801:Humans; D008107:Liver Diseases / Q000628:therapy*; D009388:Neostigmine / Q000031:analogs & derivatives; D011726:Pyridinium Compounds
D011726:Pyridinium Compounds; D009388:Neostigmine; D002802:Cholinesterases; C084645:distigmine
LIVER DISEASES/therapy; NEOSTIGMINE/related compounds
Cholinesterasehemmung bei Leberkrankheiten durch zusätzliche Belastung mit BC 51 (Ubretid).